Dr. Sreekanth C. Reddy
Claim this profileNorthside Hospital
Area of expertise
Lung Cancer
Sreekanth C. Reddy has run 6 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Sreekanth C. Reddy has run 5 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Northside Hospital
Northside Hospital - Duluth
Clinical Trials Sreekanth C. Reddy is currently running
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting
1 award
Phase 2 & 3
13 criteria
More about Sreekanth C. Reddy
Clinical Trial Related
6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Sreekanth C. Reddy has experience with
- Pembrolizumab
- Pemetrexed Disodium
- Gemcitabine Hydrochloride
- Biospecimen Collection
- Crizotinib
- Talazoparib
Breakdown of trials Sreekanth C. Reddy has run
Lung Cancer
Non-Small Cell Lung Cancer
Anaplastic Large Cell Lymphoma
ALK Gene Rearrangement
Lung Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sreekanth C. Reddy specialize in?
Sreekanth C. Reddy focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Sreekanth C. Reddy currently recruiting for clinical trials?
Yes, Sreekanth C. Reddy is currently recruiting for 2 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Sreekanth C. Reddy has studied deeply?
Yes, Sreekanth C. Reddy has studied treatments such as Pembrolizumab, Pemetrexed Disodium, Gemcitabine Hydrochloride.
What is the best way to schedule an appointment with Sreekanth C. Reddy?
Apply for one of the trials that Sreekanth C. Reddy is conducting.
What is the office address of Sreekanth C. Reddy?
The office of Sreekanth C. Reddy is located at: Northside Hospital, Atlanta, Georgia 30342 United States. This is the address for their practice at the Northside Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.